CD274 and neoplasm: Using this labelled antibody they were able to predict therapy outcome, distinguishing PD-L1-positive and PD-L1-negative xenografts in the mouse model with PET imaging, and also demonstrated therapeutic efficacy, which was highly correlated with the tumour uptake of 64Cu-NOTA-Ab1881.